» Articles » PMID: 24793591

Spin Equilibrium and O₂-binding Kinetics of Mycobacterium Tuberculosis CYP51 with Mutations in the Histidine-threonine Dyad

Overview
Journal J Inorg Biochem
Specialty Biochemistry
Date 2014 May 6
PMID 24793591
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The acidic residues of the "acid-alcohol pair" in CYP51 enzymes are uniformly replaced with histidine. Herein, we adopt the Mycobacterium tuberculosis (mt) enzyme as a model system to investigate these residues' roles in finely tuning the heme conformation, iron spin state, and formation and decay of the oxyferrous enzyme. Properties of the mtCYP51 and the T260A, T260V, and H259A mutants were interrogated using UV-Vis and resonance Raman spectroscopies. Evidence supports that these mutations induce comprehensive changes in the heme environment. The heme iron spin states are differentially sensitive to the binding of the substrate, dihydrolanosterol (DHL). DHL and clotrimazole perturb the local environments of the heme vinyl and propionate substituents. Molecular dynamics (MD) simulations of the DHL-enzyme complexes support that the observed perturbations are attributable to changes in the DHL binding mode. Furthermore, the rates of the oxyferrous formation were measured using stopped-flow methods. These studies demonstrate that both HT mutations and DHL modulate the rates of oxyferrous formation. Paradoxically, the binding rate to the H259A mutant-DHL complex was approximately four-fold that of mtCYP51, a phenomenon that is predicted to result from the creation of an additional diffusion channel from loss of the H259-E173 ion pair in the mutant. Oxyferrous enzyme auto-oxidation rates were relatively constant, with the exception of the T260V-DHL complex. MD simulations lead us to speculate that this behavior may be attributed to the distortion of the heme macrocycle by the substrate.

Citing Articles

Revealing substrate-induced structural changes in active site of human CYP51 in the presence of its physiological substrates.

Jing Y, Usai R, Liu Y, Kincaid J J Inorg Biochem. 2023; 242:112167.

PMID: 36870163 PMC: 10082466. DOI: 10.1016/j.jinorgbio.2023.112167.


Spectroscopic studies of the cytochrome P450 reaction mechanisms.

Mak P, Denisov I Biochim Biophys Acta Proteins Proteom. 2017; 1866(1):178-204.

PMID: 28668640 PMC: 5709052. DOI: 10.1016/j.bbapap.2017.06.021.


The use of isomeric testosterone dimers to explore allosteric effects in substrate binding to cytochrome P450 CYP3A4.

Denisov I, Mak P, Grinkova Y, Bastien D, Berube G, Sligar S J Inorg Biochem. 2016; 158:77-85.

PMID: 26774838 PMC: 4887402. DOI: 10.1016/j.jinorgbio.2015.12.019.

References
1.
Denisov I, Makris T, Sligar S, Schlichting I . Structure and chemistry of cytochrome P450. Chem Rev. 2005; 105(6):2253-77. DOI: 10.1021/cr0307143. View

2.
Nagano S, Cupp-Vickery J, Poulos T . Crystal structures of the ferrous dioxygen complex of wild-type cytochrome P450eryF and its mutants, A245S and A245T: investigation of the proton transfer system in P450eryF. J Biol Chem. 2005; 280(23):22102-7. DOI: 10.1074/jbc.M501732200. View

3.
Cohen J, Olsen K, Schulten K . Finding gas migration pathways in proteins using implicit ligand sampling. Methods Enzymol. 2008; 437:439-57. DOI: 10.1016/S0076-6879(07)37022-5. View

4.
Kumar D, Hirao H, de Visser S, Zheng J, Wang D, Thiel W . New features in the catalytic cycle of cytochrome P450 during the formation of compound I from compound 0. J Phys Chem B. 2006; 109(42):19946-51. DOI: 10.1021/jp054754h. View

5.
Eisenstein L, Debey P, Douzou P . P450cam: oxygenated complexes stabilized at low temperature. Biochem Biophys Res Commun. 1977; 77(4):1377-83. DOI: 10.1016/s0006-291x(77)80131-9. View